,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,192,1,1,,93570,67282,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,248,1,1,,93570,67282,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,73950,9,2,,103321687,67282,Active,,,2.5,IC50,Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).,Confirmatory,14561081.0,
3,165175,3,9,,103321687,67282,Unspecified,,,,,"First-order rate constant (K inact) for conversion of the ExI complex (Protein-tyrosine phosphatase 1B -inhibitor complex) into the covalent adduct, EI was determined using PNP as substrate",Other,12372498.0,
4,165176,9,2,,103321687,67282,Active,,,14.0,Ki,Dissociation constant towards Protein-tyrosine phosphatase 1B receptor-inhibitor complex was determined using PNP as substrate,Confirmatory,12372498.0,
5,223675,6,4,,103321687,67282,Unspecified,,,100.0,IC50,Inhibitory activity against protein kinase A (PKA ),Confirmatory,14561081.0,
6,227010,3,9,,103321687,67282,Unspecified,,,,,Ratio between dissociation constant and First-order rate constant (Ki / K inact) was determined,Other,12372498.0,
7,605820,6,2,,103321687,67282,Active,,,2.5,IC50,Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay,Confirmatory,21500862.0,
8,1259407,1,1,,363905947,67282,Inactive,,,,,CCRIS mutagenicity studies,Other,,
